ImmunoPrecise Antibodies (IPA) News Today $0.35 -0.03 (-8.03%) (As of 12:13 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics InnovationNovember 4, 2024 | businesswire.comImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised to Tap into $81 Billion Market with AI TechnologyOctober 28, 2024 | businesswire.comInstitutional Property Advisors Brokers $92.5 Million Multifamily Sale in L.A.'s NoHo Arts DistrictOctober 16, 2024 | businesswire.comImmunoPrecise Antibodies earnings preview: what Wall Street is expectingSeptember 15, 2024 | markets.businessinsider.comImmunoprecise Antibodies Ltd MediaAugust 27, 2024 | lse.co.ukImmunoPrecise Antibodies to Participate at H.C. Wainwright's 26th Annual Global Investment Conference in New YorkAugust 26, 2024 | businesswire.comImmunoPrecise Antibodies Receives Nasdaq Notification Regarding Minimum Bid RequirementsAugust 23, 2024 | businesswire.comImmunoPrecise Antibodies (IPA) Reports Financial Results and Business Updates for Fourth Quarter and Full Fiscal Year 2024July 29, 2024 | financialpost.comImmunoPrecise Antibodies to Reschedule Financial Results and Recent Business Highlights Report for Fourth Quarter and Fiscal Year-End 2024July 23, 2024 | financialpost.comImmunoPrecise Appoints Kristin Taylor as Chief Financial OfficerJune 27, 2024 | financialpost.comIPA's Subsidiary BioStrand and PGxAI Announce Strategic Collaboration to Develop First-In-Class AI Model for Pharmacogenomics Recommendations Using LENSai™June 25, 2024 | businesswire.comImmunoPrecise Antibodies Ltd. Subsidiary BioStrand Receives Prestigious 2024 Impact Award for Groundbreaking LENSai™ TechnologyJune 12, 2024 | businesswire.comBioStrand, ImmunoPrecise Antibodies' Subsidiary, Announces Immediate Commercial Offering of Groundbreaking Software with Customizable Interface for AI-Driven Drug DiscoveryJune 10, 2024 | businesswire.comIPA's Subsidiary, BioStrand, Announces Advanced Large Language Model (LLM) for Electronic Health Records (EHR)June 4, 2024 | businesswire.comImmunoPrecise Antibodies Ltd. (IPA)April 26, 2024 | finance.yahoo.comInterSystems and IPA’s Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare ApplicationsMarch 28, 2024 | finance.yahoo.comInterSystems and IPA's Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare ApplicationsMarch 28, 2024 | businesswire.comIPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI DevelopmentsMarch 20, 2024 | businesswire.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q3 2024 Earnings Call TranscriptMarch 15, 2024 | msn.comIPA Stock Earnings: ImmunoPrecise Antibodies Misses EPS, Beats Revenue for Q3 2024March 14, 2024 | investorplace.comIPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT TechnologyMarch 7, 2024 | finance.yahoo.comIPA's subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT TechnologyMarch 7, 2024 | businesswire.comIPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024March 4, 2024 | finance.yahoo.comImmunoPrecise Antibodies (NASDAQ:IPA) Shares Down 2.3% ImmunoPrecise Antibodies (NASDAQ:IPA) Trading Down 2.3%February 10, 2024 | marketbeat.comBuy Rating on ImmunoPrecise Antibodies Reflects Strong Revenue Growth and Cost Management SuccessDecember 16, 2023 | markets.businessinsider.comIPA Announces Closing of $1.265 Million Public Offering of Common SharesDecember 8, 2023 | finance.yahoo.comWhy ImmunoPrecise Antibodies (IPA) Stock Is Down 20% TodayDecember 6, 2023 | benzinga.comWhy Is ImmunoPrecise Antibodies (IPA) Stock Down 39% Today?December 6, 2023 | investorplace.comIPA Announces Pricing of $1.1 Million Public Offering of Common SharesDecember 6, 2023 | finance.yahoo.comAfter-hours movers: SentinelOne up on earnings, MongoDB sees 'sell the news' reactionDecember 5, 2023 | investing.comIPA Announces Proposed Public Offering of Common SharesDecember 5, 2023 | finance.yahoo.comImmunoPrecise Antibodies Ltd. Announces Key Board and Board Committee Chair Appointments and Second Quarter 2024 Earnings Release CallNovember 27, 2023 | businesswire.comImmunoPrecise’s BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug DiscoveryNovember 22, 2023 | finance.yahoo.comImmunoPrecise's BioStrand® Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug DiscoveryNovember 20, 2023 | benzinga.comIPA's Subsidiary, BioStrand, Provides an Update on LENSai(TM)October 25, 2023 | stockhouse.comIPA's Subsidiary, BioStrand, Provides an Update on LENSai™October 25, 2023 | benzinga.comIPA’s Subsidiary, BioStrand, Provides an Update on LENSai™October 25, 2023 | financialpost.comOvercoming the Information Integration Dilemma: Revolutionizing The Fusion Of Complex Biological DataOctober 20, 2023 | finance.yahoo.comHow ImmunoPrecise Antibodies Is Leveraging AI To Revolutionize Antibody ResearchOctober 20, 2023 | finance.yahoo.comImmunoPrecise Antibodies Announces CFO TransitionSeptember 19, 2023 | finance.yahoo.comHC Wainwright & Co. Reiterates ImmunoPrecise Antibodies (IPA) Buy RecommendationSeptember 18, 2023 | nasdaq.comImmunoPrecise Antibodies (IPA) Receives a Buy from H.C. WainwrightSeptember 18, 2023 | markets.businessinsider.comImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2024 Earnings Call TranscriptSeptember 17, 2023 | finance.yahoo.comIPA Announces Board RefreshmentSeptember 5, 2023 | finance.yahoo.comIPA Responds to 13D FilingAugust 9, 2023 | finance.yahoo.comImmunoPrecise Reports Financial Results and Recent Business Highlights for Full Fiscal Year 2023July 7, 2023 | finance.yahoo.comImmunoPrecise Antibodies's Earnings OutlookJuly 6, 2023 | msn.comIPA to Report Financial Results and Recent Business Highlights for Fourth Quarter and Fiscal Year End 2023 on July 7th, 2023.June 29, 2023 | finance.yahoo.comIPA's Subsidiary, BioStrand, Solves the Information Integration Dilemma (IID) for Systems BiologyMay 30, 2023 | finance.yahoo.comIPA to Present at Jefferies Healthcare Conference 2023May 17, 2023 | finance.yahoo.com Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump said you could learn something from this man (Ad)Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement. Here’s everything you need to know. IPA Media Mentions By Week IPA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IPA News Sentiment▼0.000.47▲Average Medical News Sentiment IPA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IPA Articles This Week▼00▲IPA Articles Average Week Get ImmunoPrecise Antibodies News Delivered to You Automatically Sign up to receive the latest news and ratings for IPA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Reviva Pharmaceuticals News Barinthus Biotherapeutics News Anebulo Pharmaceuticals News CEL-SCI News OS Therapies News Lumos Pharma News RAPT Therapeutics News NextCure News Elevation Oncology News OKYO Pharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IPA) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ImmunoPrecise Antibodies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share ImmunoPrecise Antibodies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
